Published in Cancer Weekly, April 10th, 2001
Physicians in Toronto, Ontario, reported a case study in which a patient being treated for end-stage plasma cell leukemia developed hepatitis while being treated with thalidomide. The case was reported in the April 2001 edition of the American Journal of Hematology.
Thalidomide is perhaps best known for the severe developmental effects it can produce in the unborn fetus of a woman who takes it while pregnant. However, in recent years scientists have begun to study the efficacy of thalidomide for a variety of uses, including cancer...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.